Federal Register / Vol. 63, No. 95 / Monday, May 18, 1998 / Notices 27305

Place: Holiday Inn, Georgetown, Mirage I

Meeting Room, 2101 Wisconsin Avenue,

N.W., Washington, D.C. 20037, (202) 338–

4600.

Contact Person: Dr. Anna Ramsey-Ewing,

Scientific Review Adm., 6003 Executive

Boulevard, Solar Bldg., Room 4C37,

Bethesda, MD 20892, (301) 435–8536.

Purpose/Agenda: To evaluate contract

proposals.

Name of SEP: Malaria: Clinical Research

and Trial Preparation Sites in Endemic

Areas.

Date: May 28–29, 1998.

Time: 8:00 a.m. to Adjournment.

Place: Holiday Inn, Georgetown, Mirage I

Meeting Room, 2101 Wisconsin Avenue,

N.W., Washington, D.C. 20037, (202) 338–

4600.

Contact Person: Dr. Anna Ramsey-Ewing,

Scientific Review Adm., 6003 Executive

Boulevard Solar Bldg., Room 4C37, Bethesda,

MD 20892, (301) 435–8536.

Purpose/Agenda: To evaluate contract

proposals.

These meetings will be closed in

accordance with the provisions set forth in

secs. 552b(c)(4) and 552b(c)(6), Title 5, U.S.C.

Applications and/or proposals and the

discussions could reveal confidential trade

secrets or commercial property such as

patentable material and personal information

concerning individuals associated with the

applications and/or proposals, the disclosure

of which would constitute a clearly

unwarranted invasion of personal privacy.

This notice is being published less than 15

days prior to the meeting due to the urgent

need to meet timing limitations imposed by

the review and funding cycle.

(Catalog of Federal Domestic Assistance

Programs Nos. 93.855, Immunology, Allergic

and Immunologic Diseases Research; 93.856,

Microbiology and Infectious Diseases

Research, National Institutes of Health)

Dated: May 11, 1998.

Anna Snouffer,

Acting Committee Management Officer, NIH.

[FR Doc. 98–13150 Filed 5–15–98; 8:45 am]

BILLING CODE 4140–01–M

DEPARTMENT OF HEALTH AND

HUMAN SERVICES

National Institutes of Health

National Institute of Diabetes and

Digestive and Kidney Diseases; Notice

of Closed Meetings

Pursuant to Pub. L. 92–463, notice is

hereby given of the meetings of the

Diabetes and Digestive and Kidney

Diseases Special Grant Review

Committees, National Institute of

Diabetes and Digestive and Kidney

Diseases (NIDDK) for June 1998.

Name of Committee: National Diabetes and

Digestive and Kidney Diseases Special Grant

Review Committee, Subcommittee B.

Date: June 9, 1998.

Time: 8:00 a.m.—Adjournment.

Place: HOLIDAY INN BETHESDA, 8120

Wisconsin Avenue, Bethesda, Maryland

20814, Telephone: (301) 652–2000.

Contact Person: Ned Feder, M.D., Scientific

Review Administrator, Natcher Building,

Room 6AS–25S, National Institutes of Health,

Bethesda, Maryland 20892–6600, Phone:

301–594–8890.

Name of Committee: National Diabetes and

Digestive and Kidney Diseases Special Grant

Review Committee, Subcommittee C.

Date: June 18, 1998.

Time: 8:30 a.m.—Adjournment.

Place: EMBASSY SUITES HOTEL, 1300

Jefferson Davis Highway, Crystal City,

Virginia 22202, Telephone: (703) 979–9799.

Contact Person: Daniel Matsumoto, Ph.D.,

Scientific Review Administrator, Natcher

Building, Room 6AS–37B, National Institutes

of Health, Bethesda, Maryland 20892–6600,

Phone: 301–594–8894.

Name of Committee: National Diabetes and

Digestive and Kidney Diseases Special Grant

Review Committee, Subcommittee D.

Date: June 12, 1998.

Time: 8:00 a.m.—Adjournment.

Place: DOUBLETREE HOTEL, 1750

Rockville Pike, Rockville, Maryland 20852,

Telephone: (301) 230–6783.

Contact Person: Ann A. Hagan, PH.D.,

Scientific Review Administrator, Natcher

Building, Room 6AS–37F, National Institutes

of Health, Bethesda, Maryland 20892–6600,

Phone: 301–594–8886.

Purpose/Agenda: To review and evaluate

research grant applications.

These meetings will be closed in

accordance with the provisions set forth in

secs. 552b(c)(4) and 552b(c)(6), Title 5, U.S.C.

Applications and/or proposals and the

discussions could reveal confidential trade

secrets or commercial property such as

patentable material and personal information

concerning individuals associated with the

applications and/or proposals, the disclosure

of which would constitute a clearly

unwarranted invasion of personal privacy.

(Catalog of Federal Domestic Assistance

Program No. 93.847–849, Diabetes, Endocrine

and Metabolic Diseases; Digestive Diseases

and Nutrition; and Kidney Diseases, Urology

and Hematology Research, National Institutes

of Health)

Dated: May 11, 1998.

Anna Snouffer,

Acting Committee Management Officer, NIH.

[FR Doc. 98–13151 Filed 5–15–98; 8:45 am]

BILLING CODE 4140–01–M

DEPARTMENT OF HEALTH AND

HUMAN SERVICES

National Institutes of Health

National Institute of Diabetes and

Digestive and Kidney Diseases; Notice

of Closed Meeting

Pursuant to Section 10(d) of the

Federal Advisory Committee Act, as

amended (5 U.S.C. Appendix 2), notice

is hereby given of the following

National Institute of Diabetes and

Digestive and Kidney Diseases Special

Emphasis Panel meeting:

Name of SEP: ZDK1 GRB–5–01 P.

Date: June 22–24, 1998.

Time: 7:30 PM.

Place: Radisson Hotel Dallas, 1893 West

Mockingbird Lane, Dallas, Texas 75235,

Telephone: (214) 634–8850.

Contact: Francisco O. Calvo, Ph.D., Chief,

Special Emphasis Panel, Review Branch,

DEA, NIDDK, Natcher Building, Room 6AS–

37E, National Institutes of Health, Bethesda,

Maryland 20892–6600, Phone: (301) 594–

8897.

Purpose/Agenda: To review and evaluate

grant applications.

This meeting will be closed in accordance

with the provisions set forth in secs.

552b(c)(4) and 552b(c)(6), Title 5 U.S.C.

Applications and/or proposals and the

discussions could reveal confidential trade

secrets or commercial property such as

patentable material and personal information

concerning individuals associated with the

applications and/or proposals, the disclosure

of which would constitute a clearly

unwarranted invasion of personal privacy.

(Catalog of Federal Domestic Assistance

Program No. 93.847–849, Diabetes, Endocrine

and Metabolic Diseases; Digestive Diseases

and Nutrition; and Kidney Diseases, Urology

and Hematology Research, National Institutes

of Health.)

Dated: May 11, 1998.

Anna Snouffer,

Acting NIH Committee Management Officer,

NIH.

[FR Doc. 98–13152 Filed 5–15–98; 8:45 am]

BILLING CODE 4140–01–M

DEPARTMENT OF HEALTH AND

HUMAN SERVICES

National Institutes of Health

National Institute on Drug Abuse;

Notice of Closed Meeting

Pursuant to Section 10(d) of the

Federal Advisory Committee Act, as

amended (5 U.S.C. Appendix 2), notice

is hereby given of the following

National Institute on Drug Abuse

(NIDA) Special Emphasis Panel

meeting.

Purpose/Agenda: To review and evaluate

contract proposals.

Name of Committee: NIDA Special

Emphasis Panel (contract Review—‘‘NIDA

Notes’’).

Date: May 14, 1998.

Time: 9:30 a.m.

Place: Parklawn Building, Conference A,

3rd Floor, 5600 Fishers Lane, Rockville, MD

20857.

Contact Person: Mr. Lyle Furr, Review

Administrator, Office of Extramural Program

Review, National Institute on Drug Abuse,

5600 Fishers Lane, Room 10–42, Telephone

(301) 443–1644.